These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 13481746)

  • 1. PSYCHODYNAMIC and therapeutic aspects of mescaline and lysergic acid diethylamide: round table.
    J Nerv Ment Dis; 1957; 125(3):423-4. PubMed ID: 13481746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Similarities and dissimilarities of experimental psychoses caused by LSD-25 and mescaline].
    VOJTECHOVSKY M; GROF S
    Cesk Psychiatr; 1960 Aug; 56():221-33. PubMed ID: 13781932
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychoses-producing and psychoses-relieving drugs.
    HOCH PH
    Res Publ Assoc Res Nerv Ment Dis; 1958; 36():335-46. PubMed ID: 13527792
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental contribution to the problem of possible crossed tolerance between psychotic drugs of different structure].
    MISSERE G; TONINI G
    Boll Soc Ital Biol Sper; 1959 Sep; 35():1119-20. PubMed ID: 14422940
    [No Abstract]   [Full Text] [Related]  

  • 5. Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.
    FREEDMAN DX; AGHAJANIAN GK; ORNITZ EM
    Science; 1958 May; 127(3307):1173-4. PubMed ID: 13555858
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged survival of the isolated retina induced by drugs; strychnine, mescaline, d-lysergic acid diethylamide (LSD), and atropine.
    APTER JT
    AMA Arch Ophthalmol; 1958 May; 59(5):722-30. PubMed ID: 13519998
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G
    Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental psychoses and schizophrenia].
    Morselli GE
    Riv Neurobiol; 1964; 10(4):Suppl:1170-6. PubMed ID: 5827094
    [No Abstract]   [Full Text] [Related]  

  • 9. Antidiuresis in man following lysergic acid diethylamide and mescaline.
    Hollister LE; Kanter SL; Dronkert A
    Behav Neuropsychiatry; 1970; 2(3):50-4. PubMed ID: 4913153
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine.
    CLARK LD; BLISS EL
    AMA Arch Neurol Psychiatry; 1957 Dec; 78(6):653-5. PubMed ID: 13478222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Model psychoses and lysergic acid diethylamide treatment].
    GEERT-JORGENSEN E
    Ugeskr Laeger; 1961 Oct; 123():1452-5. PubMed ID: 13897484
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 13. Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli.
    Hirschhorn ID; Winter JC
    Psychopharmacologia; 1971; 22(1):64-71. PubMed ID: 5119576
    [No Abstract]   [Full Text] [Related]  

  • 14. [FUNDAMENTALS OF A CONDITIONAL-GENETIC PSYCHOPATHOLOGY AS EXEMPLIFIED BY EXPERIMENTAL PSYCHOSIS].
    LEUNER H
    Nervenarzt; 1963 May; 34():198-206. PubMed ID: 14157764
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of rhinencephalic electrograms with behavior; a study on humans under the influence of LSD and mescaline.
    MONROE RR; HEATH RG; MICKLE WA; LLEWELLYN RC
    Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):623-42. PubMed ID: 13480236
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 17. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Change in complex forms of conditioned reflexes caused by the application of lysergic acid diethylamide (LSD) and mescaline to the cortical ends of the auditory and visual analyzers].
    Alekseeva LA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1969; 19(2):279-85. PubMed ID: 5404353
    [No Abstract]   [Full Text] [Related]  

  • 19. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 20. Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application.
    FABING HD
    Neurology; 1955 May; 5(5):319-28. PubMed ID: 14370384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.